Regulation - Cometriq

Filter

Current filters:

Cometriq

Popular Filters

FDA approves Exelixis' Cometriq for rare thyroid cancer, as EMA accepts filing

30-11-2012

There were two items of good news yesterday for US drug developer Exelixis' (Nasdaq: EXEL), the first…

AstraZenecaBiotechnologycabozantinibCaprelsaCometriqEuropeExelixisNorth AmericaOncologyPharmaceuticalRegulation

Parexel

Parexel

Back to top